Generation of CD34+ cells from CCR5-disrupted human embryonic and induced pluripotent stem cells.
about
Newer gene editing technologies toward HIV gene therapySite-Specific Genome Engineering in Human Pluripotent Stem CellsOrigins of Programmable Nucleases for Genome EngineeringTargeted gene disruption to cure HIVZinc finger endonuclease targeting PSIP1 inhibits HIV-1 integration.Synergistic contribution of SMAD signaling blockade and high localized cell density in the differentiation of neuroectoderm from H9 cellsGenomic editing tools to model human diseases with isogenic pluripotent stem cells.Targeted genome engineering in human induced pluripotent stem cells by penetrating TALENs.Generation of CCR5-defective CD34 cells from ZFN-driven stop codon-integrated mesenchymal stem cell clones.Negligible immunogenicity of induced pluripotent stem cells derived from human skin fibroblasts.Genome editing strategies: potential tools for eradicating HIV-1/AIDS.Generation and genetic engineering of human induced pluripotent stem cells using designed zinc finger nucleases.Introducing precise genetic modifications into human 3PN embryos by CRISPR/Cas-mediated genome editing.The clinical applications of genome editing in HIV.New frontier in regenerative medicine: site-specific gene correction in patient-specific induced pluripotent stem cellsNew and TALENted genome engineering toolbox.MicroRNAs and induced pluripotent stem cells for human disease mouse modeling.HIV/AIDS: modified stem cells in the spotlight.Use of the heteroduplex mobility assay and cell sorting to select genome sequences of the CCR5 gene in HEK 293T cells edited by transcription activator-like effector nucleases.Personalized gene therapy locks out HIV, paving the way to control virus without antiretroviral drugs.Modern Genome Editing Technologies in Huntington's Disease Research.Novel AIDS therapies based on gene editing.Therapeutic gene editing: delivery and regulatory perspectivesFight fire with fire: Gene therapy strategies to cure HIV.Targeted Gene Editing in Human Pluripotent Stem Cells Using Site-Specific Nucleases.
P2860
Q24631042-659F6006-D815-4BA0-851F-A82D368929AEQ26747006-E56D9210-DAC4-492D-A94B-844094D242DFQ26778501-101190BD-FDD9-496D-89F9-E8728AC67EF5Q27023171-A0930E3D-1DBD-44B1-B51B-997253EFDFEEQ34058383-0B911748-940B-402C-B2C3-D49FA12AB308Q34324040-6AACE2D9-7681-43C2-B965-5336C3644DB7Q34437293-0657CCC4-3204-44B8-A22E-0E30475AFCD3Q34504908-B28AFE27-81E4-41BD-8F9E-5CE99387DDD6Q35232745-DA8BBEC9-8CE4-41B1-A5BC-6AF97AF4E470Q35517873-336432AE-DEDB-47C8-87F5-FAE84268109FQ35612053-1589C61F-227B-4CAB-A672-9A61755D100BQ36590372-BE02C41D-004B-4F1B-BD0A-C5C68B2CA926Q36910225-8FF5ADEB-8CF2-4387-AC44-E205DF15FD55Q36942032-6602F8ED-D53E-48DB-B678-F871370C0D37Q36945734-05228D4A-2C9F-4466-B332-CEDC7A5B4067Q37662636-BA5C8010-8F67-4309-9FDB-8E828AF2B7B4Q38012445-B567957E-FE94-42AC-B130-6D9A85312E0BQ38186557-1EC8F962-F2ED-451C-B057-7437209AA92EQ38334508-6C9F0402-A181-4CDD-AE47-374E054D64A6Q38462651-CE49BEAC-3764-4683-9EB2-67B3B2F0053BQ39106522-3F4563F2-21BB-44AD-BE50-30FE32442FB6Q39140209-19FAE1DE-DCE0-4329-97EB-A5F55EC9EE71Q39230418-3E4018A5-5600-46E2-83F7-158FE35080C5Q39425614-E872F3FE-A44E-4067-8063-46B615BD5B74Q48546000-2B76C337-93CD-4FB9-B0FF-6D91AA575D0B
P2860
Generation of CD34+ cells from CCR5-disrupted human embryonic and induced pluripotent stem cells.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Generation of CD34+ cells from ...... nduced pluripotent stem cells.
@en
Generation of CD34+ cells from ...... nduced pluripotent stem cells.
@nl
type
label
Generation of CD34+ cells from ...... nduced pluripotent stem cells.
@en
Generation of CD34+ cells from ...... nduced pluripotent stem cells.
@nl
prefLabel
Generation of CD34+ cells from ...... nduced pluripotent stem cells.
@en
Generation of CD34+ cells from ...... nduced pluripotent stem cells.
@nl
P2093
P356
P1433
P1476
Generation of CD34+ cells from ...... nduced pluripotent stem cells.
@en
P2093
Bayaer Nashun
Jianyong Xu
Miguel A Esteban
Siting Zhao
Tiancheng Zhou
Xiaoping Chen
Yongchao Yao
P304
P356
10.1089/HUM.2011.126
P577
2011-12-14T00:00:00Z